Triple

T23466163
Position Surface form Disambiguated ID Type / Status
Subject TOXNET E569107 entity
Predicate providesAccessTo P1985 FINISHED
Object Chemical Carcinogenesis Research Information System — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Chemical Carcinogenesis Research Information System | Statement: [TOXNET, providesAccessTo, Chemical Carcinogenesis Research Information System]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Chemical Carcinogenesis Research Information System
Context triple: [TOXNET, providesAccessTo, Chemical Carcinogenesis Research Information System]
  • A. ICH S1 Carcinogenicity Studies Guidelines
    The ICH S1 Carcinogenicity Studies Guidelines are international harmonized standards that outline when and how long-term animal carcinogenicity studies should be conducted to assess the cancer-causing potential of new pharmaceuticals.
  • B. IARC Monographs on the Identification of Carcinogenic Hazards to Humans
    The IARC Monographs on the Identification of Carcinogenic Hazards to Humans are authoritative scientific evaluations that classify agents, mixtures, and exposures according to their potential to cause cancer in humans.
  • C. TOXNET
    TOXNET is an online database system providing access to toxicology, hazardous chemicals, and environmental health information developed by the U.S. National Library of Medicine.
  • D. Report on Carcinogens
    The Report on Carcinogens is an authoritative, periodically updated U.S. government publication that identifies and profiles substances known or reasonably anticipated to cause cancer in humans.
  • E. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
    ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Chemical Carcinogenesis Research Information System
Target entity description: The Chemical Carcinogenesis Research Information System is a specialized database that compiles and organizes scientific information on chemicals with potential cancer-causing properties.
  • A. ICH S1 Carcinogenicity Studies Guidelines
    The ICH S1 Carcinogenicity Studies Guidelines are international harmonized standards that outline when and how long-term animal carcinogenicity studies should be conducted to assess the cancer-causing potential of new pharmaceuticals.
  • B. IARC Monographs on the Identification of Carcinogenic Hazards to Humans
    The IARC Monographs on the Identification of Carcinogenic Hazards to Humans are authoritative scientific evaluations that classify agents, mixtures, and exposures according to their potential to cause cancer in humans.
  • C. TOXNET chosen
    TOXNET is an online database system providing access to toxicology, hazardous chemicals, and environmental health information developed by the U.S. National Library of Medicine.
  • D. Report on Carcinogens
    The Report on Carcinogens is an authoritative, periodically updated U.S. government publication that identifies and profiles substances known or reasonably anticipated to cause cancer in humans.
  • E. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
    ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
  • F. None of above.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2458ebd808190b3298163132cfb0b completed April 17, 2026, 2:37 p.m.
NER Named-entity recognition batch_69f1a6faaf8c8190b4fd191c54e1acea completed April 29, 2026, 6:36 a.m.
Created at: April 17, 2026, 5:54 p.m.